Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apofri is a Swedish pharmaceutical company that operates as a subsidiary of Apoteket AB, the country's state-owned pharmacy retailer. The company focuses on providing a comprehensive range of over-the-counter (OTC) medicines and consumer healthcare products. Its portfolio includes generic versions of widely used drugs for pain relief, allergy management, and cold symptoms, as well as vitamins and skincare items. Apofri's mission is to offer high-quality, affordable alternatives to brand-name pharmaceuticals, ensuring broad access to essential health products. The brand is a staple in the Swedish market, distributed exclusively through Apoteket's retail and online channels. By leveraging the supply chain and reputation of its parent company, Apofri has become one of the leading private-label pharmaceutical brands in Scandinavia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apofri.